CNS Stimulants and Related Drugs – Key Vocabulary

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/74

flashcard set

Earn XP

Description and Tags

A comprehensive set of vocabulary flashcards covering key terms, drugs, mechanisms, indications, contraindications, adverse effects, and nursing considerations related to CNS stimulants and associated therapies.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

75 Terms

1
New cards

Central Nervous System (CNS)

Brain and spinal cord; target or source of most stimulant drug actions and adverse effects.

2
New cards

Excitatory Neurotransmitter

Chemical (e.g., dopamine, norepinephrine, serotonin) that increases neuronal activity in the CNS.

3
New cards

Dopaminergic Drug

Medication that stimulates dopamine receptors to raise CNS activity (e.g., amphetamines).

4
New cards

Adrenergic Drug

Agent that stimulates norepinephrine receptors, producing sympathomimetic CNS effects.

5
New cards

Serotonergic Drug

Drug that acts on serotonin receptors; includes migraine medicines called triptans.

6
New cards

Sympathomimetic Drug

Substance that mimics sympathetic nervous system activity; many CNS stimulants belong here.

7
New cards

CNS Stimulant

Drug that increases neuronal activity in selected brain/spinal cord areas, improving alertness or respiration.

8
New cards

Amphetamine (Class)

Powerful CNS stimulants that elevate mood, alertness, and wakefulness; treat ADHD and narcolepsy.

9
New cards

Xanthine (Class)

Naturally occurring stimulants (e.g., caffeine, theophylline) that enhance respiration via phosphodiesterase inhibition.

10
New cards

Attention-Deficit/Hyperactivity Disorder (ADHD)

Common childhood psychiatric disorder marked by inattention, hyperactivity, and impulsivity.

11
New cards

Narcolepsy

Incurable neurologic disorder characterized by unexpected "sleep attacks" during daytime activities.

12
New cards

Cataplexy

Sudden skeletal-muscle weakness often accompanying narcolepsy episodes.

13
New cards

Obesity

Medical condition defined by BMI ≥ 30 and associated with multiple health risks.

14
New cards

Body Mass Index (BMI)

Weight-for-height index; 25–29.9 = overweight, ≥ 30 = obese.

15
New cards

Migraine

Recurring unilateral or bilateral pulsating headache lasting 4–72 h with nausea, photophobia, & phonophobia.

16
New cards

Photophobia

Sensitivity or avoidance of light, commonly accompanying migraines.

17
New cards

Phonophobia

Sensitivity or avoidance of sound, often present during migraine attacks.

18
New cards

Analeptic

Drug that stimulates CNS areas controlling respiration; used for neonatal apnea or post-anesthetic depression.

19
New cards

Theophylline

Methylxanthine analeptic used to stimulate breathing in neonatal apnea and COPD.

20
New cards

Aminophylline

IV pro-drug of theophylline providing respiratory stimulation.

21
New cards

Caffeine (Pharmacologic)

Methylxanthine CNS stimulant found in beverages, OTC NoDoz, and prescription combos (Fioricet/Fiorinal).

22
New cards

Doxapram (Dopram)

IV analeptic for respiratory depression or COPD hypercapnia; requires reflex monitoring.

23
New cards

Methylphenidate (Ritalin)

First-line stimulant for ADHD and narcolepsy; available in multiple extended-release forms.

24
New cards

Modafinil (Provigil)

Schedule IV non-amphetamine that promotes wakefulness in narcolepsy and shift-work sleep disorder.

25
New cards

Armodafinil (Nuvigil)

R-enantiomer of modafinil with similar wake-promoting effects and low abuse potential.

26
New cards

Atomoxetine (Strattera)

Non-stimulant norepinephrine reuptake inhibitor for ADHD; carries warning for suicidal thoughts in adolescents.

27
New cards

Lisdexamfetamine (Vyvanse)

Pro-drug converted to dextroamphetamine; treats ADHD with lower abuse risk.

28
New cards

Mechanism of Amphetamines

Increase synaptic dopamine & norepinephrine, elevating mood, alertness, and capacity for work.

29
New cards

Respiratory Effects (Amphetamines)

Bronchodilation, increased respiratory rate, and pulmonary artery dilation.

30
New cards

Recent MAOI Usage

Contraindication to stimulants due to risk of hypertensive crisis.

31
New cards

Amphetamine Adverse Effects

Palpitations, tachycardia, hypertension, insomnia, anxiety, nausea, diarrhea, dry mouth, urinary frequency.

32
New cards

Phentermine (Ionamin)

Sympathomimetic anorexiant structurally related to amphetamines but with lower abuse potential.

33
New cards

Benzphetamine (Regimex)

Prescription anorexiant approved for short-term obesity management.

34
New cards

Methamphetamine (Desoxyn)

Controlled anorexiant/stimulant reserved for refractory obesity; high abuse potential.

35
New cards

Diethylpropion (Tenuate)

Appetite-suppressant anorexiant approved for weight loss therapy.

36
New cards

Anorexiant Mechanism

Suppress hypothalamic appetite center, increase basal metabolic rate, mobilize fat, and reduce fat absorption.

37
New cards

Orlistat (Xenical)

Non-stimulant obesity drug that inhibits intestinal lipase, preventing ~30 % of dietary fat absorption.

38
New cards

Qsymia

Combination of phentermine and topiramate used to aid chronic weight management.

39
New cards

Contrave ER

Extended-release naltrexone and bupropion formulation for weight loss.

40
New cards

Saxenda (Liraglutide)

GLP-1 agonist injectable for obesity; marketed as Victoza for type 2 diabetes.

41
New cards

Triptan

Selective serotonin (5-HT1) receptor agonist that aborts acute migraine by cranial vasoconstriction.

42
New cards

Sumatriptan (Imitrex)

Prototype triptan available PO, SC, and nasal spray for rapid migraine relief.

43
New cards

Ergot Alkaloid

Older migraine therapy that constricts cerebral vessels; includes ergotamine and D.H.E. 45.

44
New cards

Dihydroergotamine Mesylate

Injectable or nasal ergot alkaloid (Migranal) for acute migraine treatment.

45
New cards

Ergotamine Tartrate with Caffeine (Cafergot)

Tablet combining ergotamine and caffeine to treat migraines.

46
New cards

Calcitonin Gene-Related Peptide (CGRP) Inhibitor

Injectable or oral monoclonal antibody/antagonist class for migraine prevention or acute treatment.

47
New cards

Onabotulinumtoxin A (Botox)

Injected every 12 weeks for chronic migraine; BBW for systemic toxin spread.

48
New cards

Triptan Adverse Effects

Tingling, flushing, injection-site irritation, and potential dangerous hypertension.

49
New cards

Ergot Adverse Effects

Nausea, vomiting, cold extremities, muscle pain, dizziness.

50
New cards

Analeptic Mechanism (Methylxanthines)

Phosphodiesterase inhibition → ↑ cAMP → CNS respiratory stimulation.

51
New cards

Caffeine Contraindications

Use cautiously with peptic ulcer, recent MI, or dysrhythmias due to stimulant effects.

52
New cards

Doxapram Indication

Respiratory depression from anesthesia, drug overdose, or COPD with hypercapnia.

53
New cards

Drug Holiday

Planned break from stimulant therapy to reduce tolerance and assess ongoing ADHD need.

54
New cards

ADHD Dosing Timing

Give last stimulant dose 4–6 h before bedtime; take 30–45 min before meals on empty stomach.

55
New cards

Anorexiant Caffeine Avoidance

Patients must eliminate caffeine to reduce additive stimulant effects and insomnia.

56
New cards

Vitamin Supplementation with Orlistat

Fat-soluble vitamins (A, D, E, K) may be needed because drug blocks fat absorption.

57
New cards

Serotonin Receptor Agonist Forms

Available as dissolvable wafers, nasal sprays, and self-injectables for migraine self-management.

58
New cards

Amphetamine Examples

Dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate, amphetamine aspartate (Adderall).

59
New cards

Atomoxetine Black Box Warning

Risk of suicidal ideation in pediatric/adolescent ADHD patients; requires close monitoring.

60
New cards

Schedule IV Drug

Federal classification for modafinil/armodafinil due to low but present abuse potential.

61
New cards

Analeptic Vagal Effects

May increase gastric secretions, cause diarrhea, and reflex tachycardia.

62
New cards

Anorexiant Indications

Adjunct to diet & exercise for weight loss, typically restricted to higher-risk obese patients.

63
New cards

Hypertension Risk with Triptans

Serotonin agonists can significantly raise BP; contraindicated in uncontrolled hypertension.

64
New cards

Lipase

Intestinal enzyme inhibited by Orlistat to block dietary fat breakdown and absorption.

65
New cards

Basal Metabolic Rate (BMR)

Energy expenditure at rest; anorexiants increase it to aid weight loss.

66
New cards

Cyclic Adenosine Monophosphate (cAMP)

Intracellular messenger elevated by methylxanthines, leading to respiratory stimulation.

67
New cards

Phosphodiesterase Inhibition

Mechanism whereby xanthines prevent cAMP breakdown, boosting CNS activity.

68
New cards

5-HT1 Receptor

Serotonin receptor subtype stimulated by triptans to constrict cerebral vessels.

69
New cards

Abortive Migraine Therapy

Treatment given during migraine aura/onset to stop headache progression (e.g., triptans).

70
New cards

Vasoconstriction (Triptans)

Narrowing of cerebral arteries that relieves migraine pain but may raise blood pressure.

71
New cards

Botox Black Box Warning

Potential spread of botulinum toxin beyond injection site causing swallowing or breathing problems.

72
New cards

Self-Injectable Triptan

Sumatriptan SC formulation allowing patients rapid at-home migraine relief.

73
New cards

Neonatal Apnea

Breathing pauses in premature infants; often treated with caffeine or theophylline.

74
New cards

COPD-Induced Hypercapnia

Elevated CO₂ in COPD patients; doxapram may stimulate ventilation.

75
New cards

Sympathomimetic Anorexiant

Appetite suppressant that activates adrenergic pathways (e.g., phentermine).